Medical devices, healthcare technology and the business of care
510(k) clearance · K254087

MAXFRAME AUTOSTRUT with Bluetooth Multi-Axial Correction System

Synthes (USA) Products LLC · Decision date Jun 11, 2026

FDA DECISIONK254087

What did the FDA decide?

FDA records K254087 as a 510(k) premarket notification, with a decision dated Jun 11, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Jun 11, 2026

FDA source record

Regulatory record facts

Identifier
K254087
Regulatory pathway
510(k) premarket notification
Product code
KTT
Decision code
SESE
Decision date
Jun 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Appliance, Fixation, Nail/Blade/Plate Combination, Multiple Component.

Product code
KTT
FDA device class
2

FDA decision timeline

  1. K254087 received

    Application receipt date recorded by FDA.

  2. K254087 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code KTT

Product / regulatory recordCompanyPathwayDecision dateSource
Response Ortho Solutions, LLC510(k) clearanceOct 2, 2026FDA
Vilex, LLC510(k) clearanceApr 17, 2026FDA
Stabiliz Orthopaedics, Inc.510(k) clearanceMar 23, 2026FDA
Blue Ocean Global510(k) clearanceJan 20, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Synthes (USA) Products LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
West Chester, PA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records